Home > > > > Report Detail

Substance (Drug) Abuse - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Substance (Drug) Abuse - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Substance (Drug) Abuse epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Substance (Drug) Abuse Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Substance (Drug) Abuse in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Substance (Drug) Abuse outlook. It also includes the explanation of changing trends of epidemiology outlining the Substance (Drug) Abuse scenario.

Substance (Drug) Abuse Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Substance (Drug) Abuse thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Substance (Drug) Abuse explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Substance (Drug) Abuse Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Substance (Drug) Abuse

Key assessments

- Patient Segmentation in Substance (Drug) Abuse

- Substance (Drug) Abuse Risk & Burden

- Factors driving growth in a specific Substance (Drug) Abuse patient population

Substance (Drug) Abuse - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Substance (Drug) Abuse Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Substance (Drug) Abuse in 2016
2.2. Patient Share Distribution of Substance (Drug) Abuse in 2028
3. Disease Background and Overview: Substance (Drug) Abuse
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Substance (Drug) Abuse in 7MM
4.3. Total Prevalent/ Incident Patient Population of Substance (Drug) Abuse in 7MM - By Countries
5. Epidemiology of Substance (Drug) Abuse by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.1.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.1.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.1.5. Diagnosed Cases of the Substance (Drug) Abuse
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.4.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.4.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.4.5. Diagnosed Cases of the Substance (Drug) Abuse
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.5.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.5.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.5.5. Diagnosed Cases of the Substance (Drug) Abuse
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.6.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.6.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.6.5. Diagnosed Cases of the Substance (Drug) Abuse
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.7.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.7.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.7.5. Diagnosed Cases of the Substance (Drug) Abuse
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.8.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.8.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.8.5. Diagnosed Cases of the Substance (Drug) Abuse
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Substance (Drug) Abuse
5.9.3. Sub-Type Specific cases of the Substance (Drug) Abuse *
5.9.4. Sex- Specific Cases of the Substance (Drug) Abuse *
5.9.5. Diagnosed Cases of the Substance (Drug) Abuse
6. Unmet Needs of the Substance (Drug) Abuse
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Substance (Drug) Abuse in 7MM
Table 2: Total Prevalent/Incident Cases of the Substance (Drug) Abuse in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Substance (Drug) Abuse in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Substance (Drug) Abuse in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Substance (Drug) Abuse in United States (2016-2028)*
Table 6: Diagnosed Cases of the Substance (Drug) Abuse in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Substance (Drug) Abuse in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Substance (Drug) Abuse in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Substance (Drug) Abuse in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Substance (Drug) Abuse in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Substance (Drug) Abuse in France (2016-2028)
Table 12: Sub-Type Specific cases of the Substance (Drug) Abuse in France (2016-2028) *
Table 13: Sex- Specific Cases of the Substance (Drug) Abuse in France (2016-2028) *
Table 14: Diagnosed Cases of the Substance (Drug) Abuse in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Substance (Drug) Abuse in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Substance (Drug) Abuse in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Substance (Drug) Abuse in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Substance (Drug) Abuse in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Substance (Drug) Abuse in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Substance (Drug) Abuse in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Substance (Drug) Abuse in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Substance (Drug) Abuse in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Substance (Drug) Abuse in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Substance (Drug) Abuse in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Substance (Drug) Abuse in UK (2016-2028) *
Table 26: Diagnosed Cases of the Substance (Drug) Abuse in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Substance (Drug) Abuse in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Substance (Drug) Abuse in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Substance (Drug) Abuse in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Substance (Drug) Abuse in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Substance (Drug) Abuse in 7MM
Figure 2: Total Prevalent/Incident Cases of the Substance (Drug) Abuse in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Substance (Drug) Abuse in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Substance (Drug) Abuse in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Substance (Drug) Abuse in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Substance (Drug) Abuse in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Substance (Drug) Abuse in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Substance (Drug) Abuse in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Substance (Drug) Abuse in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Substance (Drug) Abuse in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Substance (Drug) Abuse in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Substance (Drug) Abuse in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Substance (Drug) Abuse in France (2016-2028) *
Figure 14: Diagnosed Cases of the Substance (Drug) Abuse in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Substance (Drug) Abuse in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Substance (Drug) Abuse in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Substance (Drug) Abuse in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Substance (Drug) Abuse in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Substance (Drug) Abuse in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Substance (Drug) Abuse in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Substance (Drug) Abuse in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Substance (Drug) Abuse in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Substance (Drug) Abuse in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Substance (Drug) Abuse in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Substance (Drug) Abuse in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Substance (Drug) Abuse in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Substance (Drug) Abuse in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Substance (Drug) Abuse in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Substance (Drug) Abuse in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Substance (Drug) Abuse in Japan (2016-2028)

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs